Researchers from the Department of Infection and Immunity of the Luxembourg Institute of Health (LIH) brought forward the potential of high doses of a specific adjuvant molecule, namely CpG oligonucleotide, in successfully modulating the immune system’s allergic response to the main cat allergen Fel d 1, thereby inducing a tolerance-promoting reaction and reverting the main hallmarks of cat allergy. The researchers analysed the molecular mechanisms underlying this tolerance and proposed a pre-clinical allergen-specific immunotherapy approach to improve the treatment and control of this common type of allergy. The full study results were published very recently in the renowned international journal “Allergy”, the official journal of the European Academy of Allergy and Clinical Immunology (EAACI) and one of the top two journals worldwide in the allergy field.
Novel immunotherapy approach to treat... - Lung Conditions C...
Novel immunotherapy approach to treat cat allergy.
Written by
2greys
To view profiles and participate in discussions please or .
Read more about...
1 Reply
•
I shall send this link on to my aunt who has a very bad allergic to cats. Thanks 2greys.
Not what you're looking for?
You may also like...
My cats treats for me
My daughter brought me my cat few days after my husband died. He had been rescued and taken to a...